Researchers from Weill Cornell Medicine describe the protocol development and optimization of asymmetric-flow field-flow fractionation (AF4) technology for separating and characterizing extracellular nanoparticles (ENPs), particularly small extracellular vesicles...
Read More »
Avalon GloboCare Corp, a leading global developer of cell-based technologies and therapeutics, announced today that Weill Cornell Medicine has selected its subsidiary Genexosome Technologies’ proprietary...
Read More »
Exosomes (white ball-like structures) and exomeres (purple and yellow) secreted by melanoma tumor cells. This image was taken using a type of microscopy called Atomic force microscopy, which uses high-resolution imaging to visualize nanoparticles. Credit: Molecular Cytology Core Facility, Memorial Sloan Kettering ...
Read More »
Exosomes are nano-sized vesicles derived from the fusion of multivesicular bodies with the surrounding plasma membrane. Exosomes have various diagnostic and therapeutic potentials in cancer and...
Read More »
Researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have received two grants from the Sohn Conference Foundation to advance their investigation into how cancer spreads in children. Dr. David Lyden, the Stavros S. Niarchos Professor in Pediatric ...
Read More »
from NEJM Watch by Anthony L. Komaroff An international team led by researchers at Weill Cornell Medicine, now reports that both mouse and human tumors that characteristically home to certain organs — lung, liver and brain — secrete exosomes that ...
Read More »
Exosome RNA Exosome RNA Research & Industry News
